FDA Accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI Life Science Investing
FDA Approves Merck's KEYTRUDA® in Combination With Padcev® for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer Life Science Investing
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure Medical Device Investing
Goodness Growth Holdings Announces Amended Credit Facility and Governance Updates Psychedelics Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Large B-cell Lymphoma After One Prior Therapy Pharmaceutical Investing
Jamieson Wellness Inc. Announces Filing of Management Information Circular for Annual and Special Meeting of Shareholders Life Science Investing
